PMC:7278709 / 19385-20139
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T409 | 86-96 | SP_7 | denotes | SARS-CoV-2 |
T410 | 234-239 | CHEBI:18059;CHEBI:18059 | denotes | lipid |
T411 | 240-248 | GO:0016020 | denotes | membrane |
T412 | 305-318 | GO:0016020 | denotes | transmembrane |
T413 | 369-380 | GO:0005737 | denotes | cytoplasmic |
T414 | 414-427 | GO:0005576 | denotes | extracellular |
T415 | 428-434 | SO:0000417 | denotes | domain |
T416 | 442-447 | PG_18;PG_1 | denotes | spike |
T417 | 448-460 | PG_18;PG_1;CHEBI:17089;BV_11;CHEBI:17089 | denotes | glycoprotein |
T418 | 488-494 | SO:0000417 | denotes | domain |
T419 | 599-605 | SO:0000417 | denotes | domain |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T145 | 44-54 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T146 | 234-239 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T147 | 369-380 | Body_part | denotes | cytoplasmic | http://purl.org/sig/ont/fma/fma66835 |
T148 | 448-460 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T149 | 577-581 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T18 | 381-385 | Body_part | denotes | tail | http://purl.obolibrary.org/obo/UBERON_0002415 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T58 | 86-94 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T59 | 499-502 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
T61 | 694-697 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T229 | 44-63 | http://purl.obolibrary.org/obo/CHEBI_33708 | denotes | amino acid residues |
T230 | 44-63 | http://purl.obolibrary.org/obo/PR_000036907 | denotes | amino acid residues |
T231 | 168-174 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signal |
T232 | 175-182 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T233 | 240-248 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T234 | 381-385 | http://purl.obolibrary.org/obo/UBERON_0002415 | denotes | tail |
T235 | 496-498 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T236 | 577-581 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T237 | 691-693 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T238 | 717-719 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T239 | 717-719 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T249 | 44-54 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T250 | 44-49 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T251 | 50-54 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T252 | 175-182 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T253 | 184-186 | Chemical | denotes | SP | http://purl.obolibrary.org/obo/CHEBI_74820 |
T254 | 234-239 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T255 | 327-329 | Chemical | denotes | TM | http://purl.obolibrary.org/obo/CHEBI_55460|http://purl.obolibrary.org/obo/CHEBI_74861 |
T257 | 448-460 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T258 | 717-719 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T259 | 729-731 | Chemical | denotes | TM | http://purl.obolibrary.org/obo/CHEBI_55460|http://purl.obolibrary.org/obo/CHEBI_74861 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T111 | 0-97 | Sentence | denotes | The following locations in the sequences of amino acid residues apply specifically to SARS-CoV-2. |
T112 | 98-163 | Sentence | denotes | These vary somewhat with author, and the following are used here. |
T113 | 164-212 | Sentence | denotes | The signal peptide (SP) comprises residues 1–19. |
T114 | 213-409 | Sentence | denotes | On the inside of the lipid membrane, the carboxyl terminus (C-terminus) is comprised of the transmembrane region (TM) comprising residues 1214–1236 and the cytoplasmic tail (CT) residues1237-1273. |
T115 | 410-567 | Sentence | denotes | The extracellular domain of the spike glycoprotein is comprised of N-terminal domain (S1-NTD) comprising residues 20–286, and is of particular interest here. |
T116 | 568-640 | Sentence | denotes | The host cell receptor binding domain (RBD) comprising residues 319–541. |
T117 | 641-690 | Sentence | denotes | In summary the key regions are as follows.SP 1-19 |
T118 | 691-704 | Sentence | denotes | S1-NTD 20–286 |
T119 | 705-716 | Sentence | denotes | RBD 319-541 |
T120 | 717-728 | Sentence | denotes | S2 686-1213 |
T121 | 729-741 | Sentence | denotes | TM 1214-1236 |
T122 | 742-754 | Sentence | denotes | CT 1237-1273 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
427 | 86-96 | Species | denotes | SARS-CoV-2 | Tax:2697049 |